Literature DB >> 2455733

Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.

M Haak-Frendscho1, N Arai, K Arai, M L Baeza, A Finn, A P Kaplan.   

Abstract

Histamine-releasing factors (HRFs) have been shown to be released from a variety of human cells, including T lymphocytes and alveolar macrophages. We considered the possibility that known cytokines might possess such activity on human basophils and/or mast cells and therefore tested preparations of human recombinant IL 3, IL 4, IL 5, granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) upon a panel of basophil donors. IL 3 and GM-CSF possessed significant histamine-releasing activity in 8 of 10 and 12 of 14 subjects, respectively. In each instance, a dose response could be demonstrated. IL 4 and G-CSF had no such activity, whereas IL 5 had activity in only 2 of 14 donors tested. We conclude that IL 3 and GM-CSF represent two effective HRFs, and suggest that HRF, as isolated based upon histamine-releasing activity, is likely to be heterogeneous in terms of molecular identity. Whether previously described HRFs relate specifically to IL 3 or GM-CSF must await primary sequence analysis of HRF and/or studies with monospecific antisera.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455733      PMCID: PMC303470          DOI: 10.1172/JCI113567

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells.

Authors:  D O Thueson; L S Speck; M A Lett-Brown; J A Grant
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Skin histamine in chronic urticaria.

Authors:  P Phanuphak; A L Schocket; C M Arroyave; P F Kohler
Journal:  J Allergy Clin Immunol       Date:  1980-05       Impact factor: 10.793

3.  Assessment of tissue fluid histamine levels in patients with urticaria.

Authors:  A P Kaplan; Z Horáková; S I Katz
Journal:  J Allergy Clin Immunol       Date:  1978-06       Impact factor: 10.793

4.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

Authors:  A F Lopez; D J Williamson; J R Gamble; C G Begley; J M Harlan; S J Klebanoff; A Waltersdorph; G Wong; S C Clark; M A Vadas
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells.

Authors:  T Yokota; F Lee; D Rennick; C Hall; N Arai; T Mosmann; G Nabel; H Cantor; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

6.  Histologic studies of chronic idiopathic urticaria.

Authors:  S F Natbony; M E Phillips; J M Elias; H P Godfrey; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  1983-02       Impact factor: 10.793

7.  Production of a histamine-releasing lymphokine by antigen- or mitogen-stimulated human peripheral T cells.

Authors:  J D Sedgwick; P G Holt; K J Turner
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

8.  Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.

Authors:  E Razin; J N Ihle; D Seldin; J M Mencia-Huerta; H R Katz; P A LeBlanc; A Hein; J P Caulfield; K F Austen; R L Stevens
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

9.  A study of histamine release from human basophils and lung mast cells by products of lymphocyte stimulation.

Authors:  I C Ezeamuzie; E S Assem
Journal:  Agents Actions       Date:  1983-04

10.  A basophil-activating factor from human T lymphocytes.

Authors:  E J Goetzl; D W Foster; D G Payan
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

View more
  30 in total

1.  Chronic urticaria--a frustrating but increasingly understandable disorder.

Authors:  S I Wasserman
Journal:  West J Med       Date:  1990-03

2.  Histamine releasing activity of blood mononuclear cells is acquired by means of activation of mast cells.

Authors:  I S Gushchin; N S Prozorovsky; E M Ignatyeva; V G Chitaeva; V P Leskov
Journal:  Agents Actions       Date:  1994-06

3.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  Purification and further characterization of human mononuclear cell histamine-releasing factor.

Authors:  M L Baeza; S Reddigari; M Haak-Frendscho; A P Kaplan
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

5.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.

Authors:  M Nitschke; K Sohn; D Dieckmann; B F Gibbs; H H Wolff; U Amon
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

7.  Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity.

Authors:  T N Liao; K H Hsieh
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

8.  Phosphatidylcholine-specific phospholipase D-derived 1,2-diacylglycerol does not initiate protein kinase C activation in the RBL 2H3 mast-cell line.

Authors:  P Lin; W J Fung; A M Gilfillan
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

9.  Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates.

Authors:  A P Gillio; C Gasparetto; J Laver; M Abboud; M A Bonilla; M B Garnick; R J O'Reilly
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

10.  The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration.

Authors:  E I Korpelainen; J R Gamble; W B Smith; G J Goodall; S Qiyu; J M Woodcock; M Dottore; M A Vadas; A F Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.